VEGFA and cancer: Others orthotopic murine model once again showed that in animals treated with either DC101, bevacizumab or VEGF‐Trap (a decoy molecule trapping VEGFA) confirmed that presence of nonangiogenic cancer cells can lead to tumor progression.